{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "density functional theory", "glucokinase activators", "molecular docking", "molecular dynamics simulation", "prenylated flavonoids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34885792", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "28"}], "Language": ["eng"], "ELocationID": ["7211", "10.3390/molecules26237211"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "23", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "28"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Elucidating the Glucokinase Activating Potentials of Naturally Occurring Prenylated Flavonoids: An Explicit Computational Approach.", "Abstract": {"AbstractText": ["Glucokinase activators are considered as new therapeutic arsenals that bind to the allosteric activator sites of glucokinase enzymes, thereby maximizing its catalytic rate and increasing its affinity to glucose. This study was designed to identify potent glucokinase activators from prenylated flavonoids isolated from medicinal plants using molecular docking, molecular dynamics simulation, density functional theory, and ADMET analysis. Virtual screening was carried out on glucokinase enzymes using 221 naturally occurring prenylated flavonoids, followed by molecular dynamics simulation (100 ns), density functional theory (B3LYP model), and ADMET (admeSar 2 online server) studies. The result obtained from the virtual screening with the glucokinase revealed arcommunol B (-10.1 kcal/mol), kuwanon S (-9.6 kcal/mol), manuifolin H (-9.5 kcal/mol), and kuwanon F (-9.4 kcal/mol) as the top-ranked molecules. Additionally, the molecular dynamics simulation and MM/GBSA calculations showed that the hit molecules were stable at the active site of the glucokinase enzyme. Furthermore, the DFT and ADMET studies revealed the hit molecules as potential glucokinase activators and drug-like candidates. Our findings suggested further evaluation of the top-ranked prenylated flavonoids for their in vitro and in vivo glucokinase activating potentials."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Faloye", "ForeName": "Kolade Olatubosun", "Initials": "KO"}, {"Identifier": ["0000-0003-1077-4176"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physics, Ecole Normale Sup\u00e9rieure, University of Yaound\u00e9 1, Yaound\u00e9 BP 812, Cameroon."}, {"Identifier": [], "Affiliation": "Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universit\u00e4t, 79104 Freiburg, Germany."}], "LastName": "Bekono", "ForeName": "Boris Davy", "Initials": "BD"}, {"Identifier": ["0000-0002-8460-7429"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Fakola", "ForeName": "Emmanuel Gabriel", "Initials": "EG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Ayoola", "ForeName": "Marcus Durojaye", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Bello", "ForeName": "Oyenike Idayat", "Initials": "OI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Olajubutu", "ForeName": "Oluwabukunmi Grace", "Initials": "OG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife 220282, Nigeria."}], "LastName": "Owoseeni", "ForeName": "Onikepe Deborah", "Initials": "OD"}, {"Identifier": ["0000-0003-1604-8626"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Mahmud", "ForeName": "Shafi", "Initials": "S"}, {"Identifier": ["0000-0002-4192-1653"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Alqarni", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": ["0000-0001-5860-530X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 61441, Saudi Arabia."}], "LastName": "Al Awadh", "ForeName": "Ahmed Abdullah", "Initials": "AA"}, {"Identifier": ["0000-0002-9387-5492"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, P.O. Box 1988, Najran 61441, Saudi Arabia."}], "LastName": "Alshahrani", "ForeName": "Mohammed Merae", "Initials": "MM"}, {"Identifier": ["0000-0002-7532-6318"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Exploration and Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Obaidullah", "ForeName": "Ahmad J", "Initials": "AJ"}], "GrantList": [{"GrantID": "TURSP-2020/309", "Agency": "Taif University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Activators"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "EC 2.7.1.2", "NameOfSubstance": "Glucokinase"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Catalytic Domain"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Enzyme Activators"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Glucokinase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Matschinsky F.M., Wilson D.F. The central role of glucokinase in glucose homeostasis: A perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans. Front. Physiol. 2019;10:148. doi: 10.3389/fphys.2019.00148.", "ArticleIdList": ["10.3389/fphys.2019.00148", "PMC6435959", "30949058"]}, {"Citation": "Remedi M.S., Koster J.C., Patton B.L., Nichols C.G. ATP-sensitive K+ channel signaling in glucokinase-deficient diabetes. Diabetes. 2005;54:2925\u20132931. doi: 10.2337/diabetes.54.10.2925.", "ArticleIdList": ["10.2337/diabetes.54.10.2925", "16186394"]}, {"Citation": "Kang L., Dunn-Meynell A.A., Routh V.H., Gaspers L.D., Nagata Y., Nishimura T., Eiki J., Zhang J., Levin B.E. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes. 2006;55:412\u2013420. doi: 10.2337/diabetes.55.02.06.db05-1229.", "ArticleIdList": ["10.2337/diabetes.55.02.06.db05-1229", "16443775"]}, {"Citation": "Noguchi R., Kubota H., Yugi K., Toyoshima Y., Komori Y., Soga T., Kuroda S. The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns. Mol. Syst. Biol. 2013;9:664. doi: 10.1038/msb.2013.19.", "ArticleIdList": ["10.1038/msb.2013.19", "PMC4039368", "23670537"]}, {"Citation": "Efeyan A., Comb W.C., Sabatini D.M. Nutrient-sensing mechanisms and pathways. Nature. 2015;517:302\u2013310. doi: 10.1038/nature14190.", "ArticleIdList": ["10.1038/nature14190", "PMC4313349", "25592535"]}, {"Citation": "Nj\u00f8lstad P.R., S\u00f8vik O., Cuesta-Mu\u00f1oz A., Bj\u00f8rkhaug L., Massa O., Barbetti F., Undlien D.E., Shiota C., Magnuson M.A., Molven A., et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N. Engl. J. Med. 2001;344:1588\u20131592. doi: 10.1056/NEJM200105243442104.", "ArticleIdList": ["10.1056/NEJM200105243442104", "11372010"]}, {"Citation": "Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem. J. 2008;414:1\u201318. doi: 10.1042/BJ20080595.", "ArticleIdList": ["10.1042/BJ20080595", "18651836"]}, {"Citation": "Matschinsky F.M., Zelent B., Doliba N.M., Kaestner K.H., Vanderkooi J.M., Grimsby J., Sarabu R. Research and development of glucokinase activators for diabetes therapy: Theoretical and practical aspects. Diabetes-Perspect. Drug Ther. 2011;203:357\u2013401.", "ArticleIdList": ["21484579"]}, {"Citation": "Yellapu N.K., Kandlapalli K., Kandimalla R., Adi P.J. Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA 4. FEBS Open Biol. 2018;8:1202\u20131208. doi: 10.1002/2211-5463.12255.", "ArticleIdList": ["10.1002/2211-5463.12255", "PMC6070654", "30087826"]}, {"Citation": "Toulis K.A., Nirantharakumar K., Pourzitaki C., Barnett A.H., Tahrani A.A. Glucokinase activators for type 2 diabetes: Challenges and future developments. Drugs. 2020;80:467\u2013475. doi: 10.1007/s40265-020-01278-z.", "ArticleIdList": ["10.1007/s40265-020-01278-z", "32162273"]}, {"Citation": "Amin N.B., Aggarwal N., Pall D., Paragh G., Denney W.S., Le V., Riggs M., Calle R.A. Two dose-ranging studies with PF\u221204937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes. Diabetes Obes. Metab. 2015;17:751\u2013759. doi: 10.1111/dom.12474.", "ArticleIdList": ["10.1111/dom.12474", "25885172"]}, {"Citation": "Simons P.I., Simons N., Stehouwer C.D., Schalkwijk C.G., Schaper N.C., Brouwers M.C. Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis. PLoS ONE. 2018;13:e0206174. doi: 10.1371/journal.pone.0206174.", "ArticleIdList": ["10.1371/journal.pone.0206174", "PMC6198948", "30352097"]}, {"Citation": "Yang X., Jiang Y., Yang J., He J., Sun J., Chen F., Yang B. Prenylated flavonoids, promising nutraceuticals with impressive biological activities. Trends Food. Sci. Technol. 2015;44:93\u2013104. doi: 10.1016/j.tifs.2015.03.007.", "ArticleIdList": ["10.1016/j.tifs.2015.03.007"]}, {"Citation": "Yazaki K., Sasaki K., Tsurumaru Y. Prenylation of aromatic compounds, a key diversification of plant secondary metabolites. Phytochemistry. 2009;70:1739\u20131745. doi: 10.1016/j.phytochem.2009.08.023.", "ArticleIdList": ["10.1016/j.phytochem.2009.08.023", "19819506"]}, {"Citation": "Shen G., Huhman D., Lei Z., Snyder J., Sumner L.W., Dixon R.A. Characterization of an isoflavonoid-specific prenyltransferase from Lupinus albus. Plant Physiol. 2012;159:70\u201380. doi: 10.1104/pp.112.195271.", "ArticleIdList": ["10.1104/pp.112.195271", "PMC3375986", "22430842"]}, {"Citation": "Xu M.J., Wu B., Ding T., Chu J.H., Li C.Y., Zhang J., Wu T., Wu J., Liu S.J., Liu S.L., et al. Simultaneous characterization of prenylated flavonoids and isoflavonoids in Psoralea corylifolia L. by liquid chromatography with diode array detection and quadrupole time of flight mass spectrometry. RCM. 2012;26:2343\u20132358. doi: 10.1002/rcm.6361.", "ArticleIdList": ["10.1002/rcm.6361", "22956327"]}, {"Citation": "Jhong C.H., Riyaphan J., Lin S.H., Chia Y.C., Weng C.F. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. Biofactors. 2015;41:242\u2013251. doi: 10.1002/biof.1219.", "ArticleIdList": ["10.1002/biof.1219", "26154585"]}, {"Citation": "Bourjot M., Apel C., Martin M.T., Grellier P., Gu\u00e9ritte F., Litaudon M. Antiplasmodial, antitrypanosomal, and cytotoxic activities of prenylated flavonoids isolated from the stem bark of artocarpus styracifolius. Planta Med. 2010;76:1600\u20131604. doi: 10.1055/s-0030-1249777.", "ArticleIdList": ["10.1055/s-0030-1249777", "20379954"]}, {"Citation": "Baldi A. Computational approaches for drug design and discovery: An overview. Syst. Rev. Pharm. 2010;1:99. doi: 10.4103/0975-8453.59519.", "ArticleIdList": ["10.4103/0975-8453.59519"]}, {"Citation": "Palermo G., De Vivo M. Computational chemistry for drug discovery. Encycl. Nanotechnol. 2014;66:334\u2013395."}, {"Citation": "Sethi A., Joshi K., Sasikala K., Alvala M. Molecular docking in modern drug discovery: Principles and recent applications. Drug Discov. Develop. New Adv. 2019:27\u201339. doi: 10.1089/ars.2013.5814.", "ArticleIdList": ["10.1089/ars.2013.5814"]}, {"Citation": "Ferreira L.G., Dos Santos R.N., Oliva G., Andricopulo A.D. Molecular docking and structure-based drug design strategies. Molecules. 2015;20:13384\u201313421. doi: 10.3390/molecules200713384.", "ArticleIdList": ["10.3390/molecules200713384", "PMC6332083", "26205061"]}, {"Citation": "Marinho M.M., Almeida-Neto F.W.Q., Marinho E.M., da Silva L.P., Menezes R.R., Dos Santos R.P., Marinho E.S., de Lima-Neto P., Martins A.M. Quantum computational investigations and molecular docking studies on amentoflavone. Heliyon. 2021;7:e06079. doi: 10.1016/j.heliyon.2021.e06079.", "ArticleIdList": ["10.1016/j.heliyon.2021.e06079", "PMC7851790", "33553750"]}, {"Citation": "Yuan S., Chan H.S., Hu Z. Using PyMOL as a platform for computational drug design. Wiley Interdiscip. Rev. Rev. Comput. Mol. Sci. 2017;7:e1298. doi: 10.1002/wcms.1298.", "ArticleIdList": ["10.1002/wcms.1298"]}, {"Citation": "Mousavi S.S., Karami A., Haghighi T.M., Tumilaar S.G., Idroes R., Mahmud S., Celik I., A\u011fag\u00fcnd\u00fcz D., Tallei T.E., Emran T.B., et al. In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV\u22122. Molecules. 2021;26:5724. doi: 10.3390/molecules26185724.", "ArticleIdList": ["10.3390/molecules26185724", "PMC8470205", "34577194"]}, {"Citation": "Olasupo S.B., Uzairu A., Shallangwa G., Uba S. QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: Achemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs. J. Iran. Chem. Soc. 2020;17:1953\u20131966. doi: 10.1007/s13738-020-01902-5.", "ArticleIdList": ["10.1007/s13738-020-01902-5"]}, {"Citation": "Bhardwaj V.K., Singh R., Sharma J., Das P., Purohit R. Structural based study to identify new potential inhibitors for dualspecificity tyrosine-phosphorylation\u2014Regulated kinase. Comput. Methods Prog. Biomed. 2020;194:105494. doi: 10.1016/j.cmpb.2020.105494.", "ArticleIdList": ["10.1016/j.cmpb.2020.105494", "32447145"]}, {"Citation": "Adewole S.O., Ojewole J.A. Artocarpus communis Forst. root-bark aqueous extract and streptozotocin-induced ultrastructural and metabolic changes in hepatic tissues of Wistar rats. Afr. J. Tradit. 2007;4:397.", "ArticleIdList": ["PMC2816511", "20161908"]}, {"Citation": "Lans C.A. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J. Ethnobiol Ethnomed. 2006;2:1\u201311. doi: 10.1186/1746-4269-2-45.", "ArticleIdList": ["10.1186/1746-4269-2-45", "PMC1624823", "17040567"]}, {"Citation": "Angadi K.K., Gundampati R.K., Jagannadham M.V., Kandru A. Molecular docking studies of guggultetrol from Nymphaea pubescens with target glucokinase (GK) related to type-II Diabetes. J. Appl. Pharm. Sci. 2013;3:127."}, {"Citation": "Dami\u00e1n-Medina K., Salinas-Moreno Y., Milenkovic D., Figueroa-Y\u00e1\u00f1ez L., Marino-Marmolejo E., Higuera-Ciapara I., Lugo-Cervantes E. In silico analysis of antidiabetic potential of phenolic compounds from blue corn (Zea mays L.) and black bean (Phaseolus vulgaris L.) Heliyon. 2020;6:e03632. doi: 10.1016/j.heliyon.2020.e03632.", "ArticleIdList": ["10.1016/j.heliyon.2020.e03632", "PMC7110303", "32258479"]}, {"Citation": "Grewal A.S., Arora S., Sharma N., Singh S. In silico docking studies of compounds from Persian shallot as allosteric glucokinase activators. Plant Arch. 2020;20:3768\u20133771."}, {"Citation": "Uniyal A., Mahapatra M.K., Tiwari V., Sandhir R., Kumar R. Targeting SARS-CoV\u22122 main protease: Structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. J. Biomol. Struct. Dyn. 2020:1\u201317. doi: 10.1080/07391102.2020.1848636.", "ArticleIdList": ["10.1080/07391102.2020.1848636", "PMC7754935", "33226303"]}, {"Citation": "Ayeni A.O., Akinyele O.F., Hosten E.C., Fakola E.G., Olalere J.T., Egharevba G.O., Watkins G.M. Synthesis, crystal structure, experimental and theoretical studies of corrosion inhibition of 2-((4-(2-hydroxy\u22124-methylbenzyl) piperazin\u22121-yl) methyl)\u22125-methylphenol\u2013A Mannich base. J. Mol. Struct. 2020;1219:128539. doi: 10.1016/j.molstruc.2020.128539.", "ArticleIdList": ["10.1016/j.molstruc.2020.128539"]}, {"Citation": "Srivastava A.K., Pandey A.K., Jain S., Misra N. FT-IR spectroscopy, intra-molecular C\u2212H\u22ef O interactions, HOMO, LUMO, MESP analysis and biological activity of two natural products, triclisine and rufescine: DFT and QTAIM approaches. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015;136:682\u2013689. doi: 10.1016/j.saa.2014.09.082.", "ArticleIdList": ["10.1016/j.saa.2014.09.082", "25315865"]}, {"Citation": "Badry R., Ibrahim A., Gamal F., Shehata D., Ezzat H., Elhaes H., Ibrahim M. Electronic Properties of Polyvinyl Alcohol/TiO2/SiO2 Nanocomposites. Biointerface Res. Appl. Chem. 2020;10:6427\u20136435."}, {"Citation": "Tao Y., Han L., Li X., Han Y., Liu Z. Molecular structure, spectroscopy (FT-IR, FT-Raman), thermodynamic parameters, molecular electrostatic potential and HOMO-LUMO analysis of 2,6-dichlorobenzamide. J. Mol. Struct. 2016;1108:307\u2013314. doi: 10.1016/j.molstruc.2015.12.031.", "ArticleIdList": ["10.1016/j.molstruc.2015.12.031"]}, {"Citation": "Bhavani K., Renuga S., Muthu S. Quantum mechanical study and spectroscopic (FT-IR, FT-Raman, 13C, 1H) study, first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 2-acetoxybenzoic acid by density functional methods. Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 2015;136:1260\u20131268. doi: 10.1016/j.saa.2014.10.012.", "ArticleIdList": ["10.1016/j.saa.2014.10.012", "25456668"]}, {"Citation": "Subramanian N., Sundaraganesan N., Jayabharathi J. Molecular structure, spectroscopic (FT-IR, FT-Raman, NMR, UV) studies and first-order molecular hyperpolarizabilities of 1, 2-bis (3-methoxy\u22124-hydroxybenzylidene) hydrazine by density functional method. Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 2010;76:259\u2013269. doi: 10.1016/j.saa.2010.03.033.", "ArticleIdList": ["10.1016/j.saa.2010.03.033", "20413344"]}, {"Citation": "Obi-Egbedi N.O., Essien K.E., Obot I.B., Ebenso E.E. 1,2-Diaminoanthraquinone as corrosion inhibitor for mild steel in hydrochloric acid: Weight loss and quantum chemical study. Int. J. Electro.Sci. 2011;6:913\u2013930."}, {"Citation": "Domingo L.R., R\u00edos-Guti\u00e9rrez M., P\u00e9rez P. Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules. 2016;21:748. doi: 10.3390/molecules21060748.", "ArticleIdList": ["10.3390/molecules21060748", "PMC6273244", "27294896"]}, {"Citation": "Stefaniu A., Pintilie L. Symmetry (Group Theory) and Mathematical Treatment in Chemistry. InTech; Rijeka, Croatia: 2018. Molecular descriptors and properties of organic molecules; pp. 161\u2013176."}, {"Citation": "Ogboye R.M., Patil R.B., Famuyiwa S.O., Faloye K.O. Novel \u03b1-amylase and \u03b1-glucosidase inhibitors from selected Nigerian antidiabetic plants: An in silico approach. J. Biomol. Struct. Dyn. 2021:1\u201310. doi: 10.1080/07391102.2021.1883480.", "ArticleIdList": ["10.1080/07391102.2021.1883480", "33583331"]}, {"Citation": "Chakravorty S.J., Chan J., Greenwood M.N., Popa-Burke I., Remlinger K.S., Pickett S.D., Green D.V., Fillmore M.C., Dean T.W., Luengo J.I., et al. Nuisance compounds, PAINS filters, and dark chemical matter in the GSK HTS collection. SLAS DISCOVERY Adv. Life Sci. RD. 2018;23:532\u2013545. doi: 10.1177/2472555218768497.", "ArticleIdList": ["10.1177/2472555218768497", "29699447"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Bowers K.J., Chow D.E., Xu H., Dror R.O., Eastwood M.P., Gregersen B.A., Klepeis J.L., Kolossvary I., Moraes M.A., Sacerdoti F.D., et al. Scalable algorithms for molecular dynamics simulations on commodity clusters; Proceedings of the 2006 ACM/IEEE Conference on Supercomputing; Tampa, FL, USA. 11\u201317 November 2006; p. 43."}, {"Citation": "Release S. Maestro-Desmond Interoperability Tools. Schr\u00f6dinger; New York, NY, USA: 2017. Desmond molecular dynamics system, DE Shaw research, New York, NY, 2017."}, {"Citation": "Lu C., Wu C., Ghoreishi D., Chen W., Wang L., Damm W., Ross G.A., Dahlgren M.K., Russell E., Von Bargen C.D., et al. OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J. Chem. Theory. Comput. 2021;17:4291\u20134300. doi: 10.1021/acs.jctc.1c00302.", "ArticleIdList": ["10.1021/acs.jctc.1c00302", "34096718"]}, {"Citation": "Toukmaji A.Y., Board J.A., Jr. Ewald summation techniques in perspective: A survey. Comput. Phys. Comm. 1996;95:73\u201392. doi: 10.1016/0010-4655(96)00016-1.", "ArticleIdList": ["10.1016/0010-4655(96)00016-1"]}, {"Citation": "Zielkiewicz J. Structural properties of water: Comparison of the SPC, SPCE, TIP4P, and TIP5P models of water. J. Chem. Phys. 2005;123:104501. doi: 10.1063/1.2018637.", "ArticleIdList": ["10.1063/1.2018637", "16178604"]}, {"Citation": "Becke A.D. A new mixing of HartreeeFock and local density-functional theories. J. Chem. Phys. 1993;98:1372\u20131377. doi: 10.1063/1.464304.", "ArticleIdList": ["10.1063/1.464304"]}, {"Citation": "Yang H., Lou C., Sun L., Li J., Cai Y., Wang Z., Li W., Liu G., Tang Y. admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35:1067\u20131069. doi: 10.1093/bioinformatics/bty707.", "ArticleIdList": ["10.1093/bioinformatics/bty707", "30165565"]}, {"Citation": "Lipinski C., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "20"}, {"Year": "2021", "Month": "11", "Day": "16"}, {"Year": "2021", "Month": "11", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "10", "Hour": "1", "Minute": "8"}, {"Year": "2021", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["34885792", "PMC8659159", "10.3390/molecules26237211", "molecules26237211"]}}], "PubmedBookArticle": []}